NewLab BioQuality AG Germany, acquired by Charles River Laboratories, USA.
Zelle Biotechnology Private Limited is NewLab’s agent in India and in the last quarter of 2008, NewLab was acquired by Charles River Laboratories, USA. NewLab BioQuality AG has two GMP/GLP facilities in Cologne and Erkrath, and the company provides high quality and efficient cell bank tests, virus and TSE safety studies as well as product characterization.
Charles River is a leading provider of research models and services and preclinical and Phase I drug development services to the biopharmaceutical market. NewLab BioQuality AG is now integrated into Charles River preclinical services / biopharmaceutical services division. Together, the two companies offer one the world’s largest portfolio of biopharmaceutical services. Zelle Biotechnology extends the services of NewLab BioQuality AG and Charles River Laboratories to the scientific community of India.

Zelle Biotechnology has added the following services to their portfolio:

Cell Line Development Services
We offer fully documented CHO, BHK, rat and human cell lines, in serum-and protein-free media and compliant to regulatory requirements. Our product demonstrates good growth and expression behavior in different process systems and is tested for absence of mycoplasma and viruses. We also offer adaptation of other cell lines to serum- and protein-free growth.

Formulation Development
An optimized formulation not only ensures your drug will perform clinically but assures manufacturability, efficient technical transfer and optimal stability. We provide consultancy services for Formulation Development. Our Formulation Development team acts as an extension of your team and in partnership, effectively develop your molecules into viable clinical and ultimately, commercial drug products.